T6735 |
XL413 hydrochloride
|
2062200-97-7
|
99.82%
|
|
XL413 hydrochloride (BMS-863233 Hydrochloride) is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC 50 of 3.4 nM. XL413 hydrochloride also ex...
|
T10055 |
(Iso)-FK-480
|
167820-10-2
|
99.68%
|
|
(Iso)-FK-480 is a novel orally available cholecystokinin A (CCK-A) antagonist for investigational treatment of chronic pancreatitis.
|
TQ0062 |
Nastorazepide
|
209219-38-5
|
99.60%
|
|
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
|
T12404 |
CCK-A receptor inhibitor 1
|
137004-80-9
|
99.47%
|
|
CCK-A receptor inhibitor 1 is a potent inhibitor of the cholecystokinin A (CCK-A) receptor (IC50: 340 nM).CCK-A receptor inhibitor 1 can be used for the study of...
|
T1052 |
Proglumide
|
6620-60-6
|
99.44%
|
|
Proglumide (Binoside) is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gas...
|
T6206 |
PHA-767491
|
845714-00-3
|
99.42%
|
|
PHA-767491 (CAY10572) is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
|
T11868 |
Lorglumide sodium salt
|
1021868-76-7
|
99.32%
|
|
Lorglumide sodium salt (CR-1409 sodium salt) is an antagonist of cholecystokinin receptors (CCK).
|
T9343 |
N-Cbz-DL-tryptophan
|
13058-16-7
|
99.25%
|
|
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
|
TP2030L1 |
Gastrin I (human) acetate
|
TP2030L1
|
98.84%
|
|
Gastrin I (human) acetate (Gastrin-17 acetate) is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK...
|
T15759 |
Lintitript
|
136381-85-6
|
98.48%
|
|
Lintitript (SR 27897) is a selective antagonist of CCK1 with EC50s of 6 nM and 200 nM for CCK1 and CCK2. The Ki value is 0.2 nM for CCK1.
|
TP1198 |
Sincalide ammonium
|
70706-98-8
|
98.46%
|
|
Sincalide ammonium (CCK-8 ammonium) is a potent analog of the amino acid peptide hormone cholecystokinin (CCK), an active fragment that retains much of the biolo...
|
T68016 |
Spiroglumide
|
137795-35-8
|
98.34%
|
|
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be ...
|
T13260 |
Gastrin/CCK antagonist 1
|
162271-52-5
|
98.33%
|
|
Gastrin/CCK antagonist 1 is a potent gastrin/CCK antagonist for the study of metabolic system-related diseases.
|
T34123 |
Pranazepide
|
150408-73-4
|
98.20%
|
|
Pranazepide (FK 480) is a small molecule cholecystokinin receptor antagonist used to study digestive disorders and pancreatitis.
|
TP1931L1 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
|
TP1931L1
|
97.68%
|
|
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) is a broad spectrum neuropeptide i...
|
T14932 |
Ceruletide
|
17650-98-5
|
97.54%
|
|
Ceruletide (Caerulein) is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic e...
|
TP2030 |
Gastrin I, human
|
10047-33-3
|
96.47%
|
|
Gastrin I, human (Gastrin I (human)) is an endogenous peptide produced in the stomach that increases pepsinogen and acid secretion via the CCK2 receptor in the r...
|
T15382 |
GI 181771
|
305366-98-7
|
95.63%
|
|
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
|
T3352 |
XL413
|
1169558-38-6
|
100%
|
|
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
|
T27503L |
GV-150013X
|
151386-96-8
|
100%
|
|
GV-150013X ((S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea) is a potent CCKB antiagonist, pKi=...
|